Anbio Biotechnology (NASDAQ:NNNN – Get Free Report) saw unusually-high trading volume on Monday. 112,449 shares traded hands during trading, an increase of 48% from the average daily volume of 76,050 shares. The stock last traded at $4.1780 and had previously closed at $3.89.
Analyst Ratings Changes
Separately, Weiss Ratings raised shares of Anbio Biotechnology from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Thursday, October 8th. One analyst has rated the stock with a Hold rating. According to MarketBeat, the stock presently has an average rating of “Hold”.
Get Our Latest Stock Report on Anbio Biotechnology
Anbio Biotechnology Stock Up 4.0%
The stock’s 50 day simple moving average is $5.07 and its two-hundred day simple moving average is $16.39.
Anbio Biotechnology Company Profile
Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.
Read More
- Five stocks we like better than Anbio Biotechnology
- America’s Rare Earth Clock Is Running Out, But the Bottleneck Isn’t Where You Think
- Atlassian Tanks After Huge Run as Guidance Disappoints, But Strength Remains
- Lemonade’s Revenue Soars 73%—So Why Did Its Stock Turn Sour After Earnings?
- Anthropic’s S-1 Strengthens the Case for Broadcom’s AI Growth
Receive News & Ratings for Anbio Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anbio Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
